AQR Capital Management
EXAS

AQR Capital Management’s Exact Sciences EXAS Stock Holding History

AQR Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,229,360
Closed -$226M – 3768
2025
Q4 		$226M Buy
2,229,360
+412,183
+23% +$33.1M 0.12% 228
2025
Q3 		$97.5M Buy
1,817,177
+63,894
+4% +$3.19M 0.06% 423
2025
Q2 		$93.2M Buy
1,753,283
+741,517
+73% +$37.7M 0.08% 357
2025
Q1 		$43.6M Buy
1,011,766
+419,381
+71% +$21.2M 0.05% 499
2024
Q4 		$33.3M Buy
592,385
+337,727
+133% +$21M 0.04% 498
2024
Q3 		$16.9M Buy
254,658
+101,060
+66% +$5.7M 0.02% 676
2024
Q2 		$6.49M Sell
153,598
-399,558
-72% -$22M 0.01% 912
2024
Q1 		$38.2M Sell
553,156
-88,271
-14% -$5.58M 0.07% 351
2023
Q4 		$47.5M Buy
641,427
+313,110
+95% +$20.5M 0.09% 275
2023
Q3 		$22.4M Buy
328,317
+207,623
+172% +$17.6M 0.05% 445
2023
Q2 		$11.3M Buy
120,694
+115,346
+2,157% +$9M 0.02% 637
2023
Q1 		$356K Buy
+5,348
New +$344K ﹤0.01% 1889
2021
Q4 		– Sell
-4,007
Closed -$371K – 2222
2021
Q3 		$371K Hold
4,007
– – ﹤0.01% 1971
2021
Q2 		$498K Sell
4,007
-9,666
-71% -$1.15M ﹤0.01% 1901
2021
Q1 		$1.75M Buy
13,673
+2,198
+19% +$301K ﹤0.01% 1275
2020
Q4 		$1.52M Buy
11,475
+7,965
+227% +$963K ﹤0.01% 1304
2020
Q3 		$357K Sell
3,510
-1,706
-33% -$147K ﹤0.01% 1855
2020
Q2 		$446K Sell
5,216
-9,193
-64% -$734K ﹤0.01% 1781
2020
Q1 		$836K Sell
14,409
-1,559
-10% -$127K ﹤0.01% 1412
2019
Q4 		$1.47M Sell
15,968
-8,492
-35% -$747K ﹤0.01% 1392
2019
Q3 		$2.21M Buy
24,460
+728
+3% +$82.9K ﹤0.01% 1245
2019
Q2 		$2.8M Sell
23,732
-37,274
-61% -$3.76M ﹤0.01% 1151
2019
Q1 		$5.28M Buy
61,006
+45,118
+284% +$3.84M 0.01% 962
2018
Q4 		$1M Sell
15,888
-11,725
-42% -$805K ﹤0.01% 1511
2018
Q3 		$2.18M Sell
27,613
-28,224
-51% -$1.84M ﹤0.01% 1366
2018
Q2 		$3.34M Sell
55,837
-149,906
-73% -$8.07M ﹤0.01% 1195
2018
Q1 		$8.3M Buy
205,743
+6,406
+3% +$312K 0.01% 825
2017
Q4 		$10.5M Sell
199,337
-14,216
-7% -$759K 0.01% 773
2017
Q3 		$10.1M Sell
213,553
-6,269
-3% -$252K 0.01% 777
2017
Q2 		$7.78M Buy
219,822
+711
+0.3% +$21.9K 0.01% 868
2017
Q1 		$5.17M Buy
219,111
+86,315
+65% +$1.71M 0.01% 1011
2016
Q4 		$1.77M Buy
132,796
+2,760
+2% +$44.6K ﹤0.01% 1469
2016
Q3 		$2.41M Buy
+130,036
New +$2.29M ﹤0.01% 1330
2015
Q4 		– Sell
-49,356
Closed -$888K – 2255
2015
Q3 		$888K Sell
49,356
-20,493
-29% -$471K ﹤0.01% 1493
2015
Q2 		$2.08M Buy
69,849
+4,042
+6% +$102K ﹤0.01% 1164
2015
Q1 		$1.45M Hold
65,807
– – ﹤0.01% 1255
2014
Q4 		$1.81M Buy
65,807
+22,700
+53% +$552K ﹤0.01% 1344
2014
Q3 		$835K Buy
+43,107
New +$790K ﹤0.01% 1706
2013
Q4 		– Sell
-11,607
Closed -$137K – 2574
2013
Q3 		$137K Sell
11,607
-576,000
-98% -$7.39M ﹤0.01% 2396
2013
Q2 		$8.17M Buy
+587,607
New +$6.38M 0.03% 645

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

AQR Capital Management's EXAS Position: Q1 2026 in Review

AQR Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,229,360 shares — an estimated $226M sold.

AQR Capital Management first reported a position in EXAS in Q2 2013 and held it in 40 quarters. The position peaked at $226M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • AQR Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • AQR Capital Management sold 2,229,360 Exact Sciences shares in Q1 2026, an estimated $226M.
  • AQR Capital Management first reported a position in Exact Sciences in Q2 2013 and held it in 40 quarters.
  • AQR Capital Management's Exact Sciences position peaked at $226M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.